Text Size

Bone Density in Patients With Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Inje University
ClinicalTrials.gov Identifier:
NCT00540267
First received: October 4, 2007
Last updated: November 3, 2008
Last verified: October 2008
History of Changes

October 4, 2007
November 3, 2008
November 2007
November 2008   (final data collection date for primary outcome measure)
The change of bone mineral density [ Time Frame: cross sectional and prospective ] [ Designated as safety issue: Yes ]
Not Provided
Complete list of historical versions of study NCT00540267 on ClinicalTrials.gov Archive Site
The effects of Smoking and antipsychotic drug on BMD [ Time Frame: Cross sectional Study ] [ Designated as safety issue: Yes ]
Not Provided
Not Provided
Not Provided
 
Bone Density in Patients With Schizophrenia
Bone Mineral Density in the Korean Patients With Chronic Schizophrenia With Alcohol Abuse

People with chronic mental disorder such as schizophrenia and alcohol abuse are high risk groups for developing osteoporosis.

To evaluate the prevalence of bone mineral density in men patients with schizophrenia with alcohol abuse, the investigators will compare bone mineral density between patient with schizophrenia with and without alcohol abuse.

People with schizophrenia has been known as a high risk groups for developing osteoporosis, because of lack of exercise, poor nutrition and high rate of smoking. Those with alcohol abuse may be higher risk group than one with schizophrenia without alcohol abuse, because they frequently have several medical problems such as liver dysfunction, Vitamin D deficiency, hyperparathyroidism and those medical condition increase risk for developing osteoporosis. Also alcohol itself can increase bone loss too by disturbing bone remodeling and enhancing bone fragility. To compare the prevalence of bone mineral density in patients with schizophrenia with alcohol abuse to those without alcohol problem, we will investigate BMD in large population of Korean patients with those illnesses.
Observational
Observational Model: Case Control
Not Provided
Not Provided
Non-Probability Sample

people with schizophrenia, gaed between 18-80 years, with no endocrine disorder
  • Schizophrenia
  • Alcohol Abuse
Other: No Intervention
No Intervention
Schizophrenia
Chronic schizophrenia with aged 18-80 years
Intervention: Other: No Intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
November 2008
November 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • DSM-IV diagnosis of schizophrenia
  • Onset of illness more than 5 years.

Exclusion Criteria:

  • No severe Medical and endocrinological disorder
Both
18 Years to 80 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT00540267
BMD07, Korea Health 21 R&D Project
No
Joo Shim, Imje University Busan Paik Hospital
Inje University
Not Provided
Study Director: Joo-Cheol Shim, MD,PhD Inje University
Inje University
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP